hungry on semaglutide Still I'M NOT HUNGRY ANYMORE —

GLP-1 medications are licensed only for type 2 diabetes and weight management, not addiction treatment

Patients who should avoid or approach with caution include those with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, pancreatitis, or severe gastrointestinal conditions

When used for weight loss, GLP-1 therapies are associated with higher discontinuation rates than in diabetes, which is thought to result from higher doses and faster titration

semble aussi montrer des effets intressants chez les personnes porteuses du VIH

[DOI] [PubMed] [Google Scholar] Parker CH, Slattery C, Brennan DJ, Roux CW

No current scientific literature supports the investigation or use of R etatrutide at 60 mg